Evidence map›Paper›PMID 23535575›Full record

ArticleThe Journal of general virology2013

L74V increases the reverse transcriptase content of HIV-1 virions with non-nucleoside reverse transcriptase drug-resistant mutations L100I+K103N and K101E+G190S, which results in increased fitness.

Jiong Wang, Dongge Li, Robert A Bambara, Hongmei Yang, Carrie Dykes

Open access · greenAbstract read
In one paragraph

Article in The Journal of general virology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jiong WangDepartment of Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.
Dongge LiDepartment of Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.
Robert A BambaraDepartment of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642, USA.
Hongmei YangDepartment of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY 14642, USA.
Carrie DykesDepartment of Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.
University of Rochester Medical Center · US

Funding

Virology/Immunology CoreP30AI078498 · NIAID · UNIVERSITY OF ROCHESTER · PI DEWHURST, STEPHEN · 2008 to 2018
$14.6M
Impact of NNRTI Resistance on RNase H &HIV ReplicationR01AI041387 · NIAID · UNIVERSITY OF ROCHESTER · PI DYKES, CARRIE A · 1998 to 2011
$3.3M
NIAID NIH HHS P30 AI078498NIAID NIH HHS P30AI078498NIAID NIH HHS R01 AI041387NIAID NIH HHS R01AI41387
6 · The paper itself

Abstract

The fitness of non-nucleoside reverse transcriptase inhibitor (NNRTI) drug-resistant reverse transcriptase (RT) mutants of HIV-1 correlates with the amount of RT in the virions and the RNase H activity of the RT. We wanted to understand the mechanism by which secondary NNRTI-resistance mutations, L100I and K101E, and the nucleoside resistance mutation, L74V, alter the fitness of K103N and G190S viruses. We measured the amount of RT in virions and the polymerization and RNase H activities of mutant RTs compared to wild-type, K103N and G190S. We found that L100I, K101E and L74V did not change the polymerization or RNase H activities of K103N or G190S RTs. However, L100I and K101E reduced the amount of RT in the virions and subsequent addition of L74V restored RT levels back to those of G190S or K103N alone. We conclude that fitness changes caused by L100I, K101E and L74V derive from their effects on RT content.

Indexed as

MutationVirus ReplicationAnti-HIV AgentsCell LineDrug Resistance, ViralHIV-1HIV Reverse TranscriptaseHumansNucleosidesReverse Transcriptase InhibitorsRibonuclease HRNA-Directed DNA PolymeraseVirionAnti-HIV AgentsHIV Reverse TranscriptaseNucleosidesReverse Transcriptase InhibitorsRibonuclease HRNA-Directed DNA Polymerase

Identifiers

PMID23535575
PMCPMC3709637
OpenAlexW2116804674

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.